These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 10760076

  • 1. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR, Cleasby M, Nyirenda MJ.
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease.
    Seckl JR.
    Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721
    [Abstract] [Full Text] [Related]

  • 3. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
    Reynolds RM.
    Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
    [Abstract] [Full Text] [Related]

  • 4. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming.
    Cottrell EC, Holmes MC, Livingstone DE, Kenyon CJ, Seckl JR.
    FASEB J; 2012 May; 26(5):1866-74. PubMed ID: 22321728
    [Abstract] [Full Text] [Related]

  • 5. Prenatal glucocorticoids and long-term programming.
    Seckl JR.
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U49-62. PubMed ID: 15554887
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid programming.
    Seckl JR, Meaney MJ.
    Ann N Y Acad Sci; 2004 Dec; 1032():63-84. PubMed ID: 15677396
    [Abstract] [Full Text] [Related]

  • 7. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC, Seckl JR, Holmes MC, Wyrwoll CS.
    Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
    [Abstract] [Full Text] [Related]

  • 8. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms.
    McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD, Stewart PM.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4979-83. PubMed ID: 11600574
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring.
    Welberg LA, Seckl JR, Holmes MC.
    Eur J Neurosci; 2000 Mar; 12(3):1047-54. PubMed ID: 10762336
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.
    Seckl JR, Holmes MC.
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):479-88. PubMed ID: 17515892
    [Abstract] [Full Text] [Related]

  • 11. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action.
    Burton PJ, Waddell BJ.
    Biol Reprod; 1999 Feb; 60(2):234-40. PubMed ID: 9915986
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms.
    Seckl JR.
    Mol Cell Endocrinol; 2001 Dec 20; 185(1-2):61-71. PubMed ID: 11738795
    [Abstract] [Full Text] [Related]

  • 13. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
    Börzsönyi B, Demendi C, Pajor A, Rigó J, Marosi K, Agota A, Nagy ZB, Joó JG.
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar 20; 161(1):12-7. PubMed ID: 22239940
    [Abstract] [Full Text] [Related]

  • 14. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero.
    Bertram C, Trowern AR, Copin N, Jackson AA, Whorwood CB.
    Endocrinology; 2001 Jul 20; 142(7):2841-53. PubMed ID: 11416003
    [Abstract] [Full Text] [Related]

  • 15. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
    Edwards CR, Benediktsson R, Lindsay RS, Seckl JR.
    Steroids; 1996 Apr 20; 61(4):263-9. PubMed ID: 8733012
    [Abstract] [Full Text] [Related]

  • 16. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action.
    Waddell BJ, Benediktsson R, Brown RW, Seckl JR.
    Endocrinology; 1998 Apr 20; 139(4):1517-23. PubMed ID: 9528929
    [Abstract] [Full Text] [Related]

  • 17. The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids.
    Holmes MC, Abrahamsen CT, French KL, Paterson JM, Mullins JJ, Seckl JR.
    J Neurosci; 2006 Apr 05; 26(14):3840-4. PubMed ID: 16597738
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of placental 11β-HSD2 induced by high maternal glucocorticoid exposure mediates sex differences in placental and fetal development.
    Yu P, Zhou J, Ge C, Fang M, Zhang Y, Wang H.
    Sci Total Environ; 2022 Jun 25; 827():154396. PubMed ID: 35259391
    [Abstract] [Full Text] [Related]

  • 19. The Role of 11β-Hydroxy Steroid Dehydrogenase Type 2 in Glucocorticoid Programming of Affective and Cognitive Behaviours.
    Shearer FJG, Wyrwoll CS, Holmes MC.
    Neuroendocrinology; 2019 Jun 25; 109(3):257-265. PubMed ID: 30884491
    [Abstract] [Full Text] [Related]

  • 20. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction.
    Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, Stewart PM.
    Hum Reprod; 1998 Apr 25; 13(4):799-804. PubMed ID: 9619527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.